STOCK TITAN

Crescent Capital BDC (CCAP) Stock Price, News & Analysis

CCAP NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
2 252 sessions, November 3, 2025 to November 3, 2026
Largest daily move
-8.3% close of May 14, 2026
1-year change
-34.5% closing prices, November 3, 2025 to November 3, 2026
1-month change
+3.7% closing prices, October 2, 2026 to November 3, 2026

Company Description

Crescent Capital BDC, Inc. (NASDAQ: CCAP) is a closed-end, externally managed business development company (BDC) that focuses on providing capital solutions to middle market companies. The company’s stated objective is to maximize total return for its stockholders in the form of current income and capital appreciation. According to its public disclosures, Crescent Capital BDC seeks to achieve this by investing in debt and related equity interests of private U.S. middle-market businesses that have sound business fundamentals and strong growth prospects.

Crescent Capital BDC is incorporated in Maryland and its common stock trades on The Nasdaq Stock Market under the symbol CCAP. It has also issued 5.00% notes due 2026, which trade on the New York Stock Exchange under the symbol FCRX, as disclosed in its SEC filings. The company has elected to be regulated as a business development company under the Investment Company Act of 1940 and to be treated as a regulated investment company (RIC) for U.S. federal income tax purposes, which requires it to distribute at least 90% of its investment company taxable income to shareholders.

Business model and investment focus

Crescent Capital BDC describes its strategy as providing capital solutions to middle market companies, with a focus on generating current income from interest-bearing investments and potential capital appreciation from both debt and related equity positions. The company’s portfolio, as reported in its earnings releases, consists primarily of secured and unsecured debt instruments and equity interests. Asset types disclosed include senior secured first lien loans, unitranche first lien loans (including last-out tranches), senior secured second lien loans, unsecured debt, equity and other investments, and LLC/LP equity interests.

The company reports that a substantial portion of its portfolio by fair value is invested in first lien and unitranche first lien loans. Its periodic financial statements show investments across a large number of portfolio companies, with the portfolio diversified by investment type and sector. Crescent Capital BDC’s investment income is derived from interest income (including paid-in-kind interest), dividend income from certain investments, and other income such as consent, waiver, amendment, agency, underwriting and arranger fees.

External management and platform support

Crescent Capital BDC is externally managed by Crescent Cap Advisors, LLC, a subsidiary of Crescent Capital Group LP (“Crescent”). Crescent is described in company press releases as a global credit investment manager that has focused for decades on below investment grade credit, including senior bank loans, high yield bonds, and private senior, unitranche and junior debt securities. Crescent is headquartered in Los Angeles and maintains offices in New York, Boston, Chicago and London. Crescent BDC states that it utilizes Crescent’s extensive experience, origination capabilities and disciplined investment process in sourcing and managing its investments.

Rating agency commentary cited in recent news notes that Crescent Capital BDC benefits from its ties to the Crescent Capital Group platform, including the ability to co-invest alongside other accounts under SEC exemptive relief. That commentary also references the firm’s long operating history as a BDC and its focus on providing loans to core and lower-middle market borrowers, generally in less cyclical businesses with solid cash flow and stable operating histories, although specific portfolio composition and sector concentrations are subject to change over time.

Regulatory status and capital structure

As a BDC regulated under the Investment Company Act of 1940, Crescent Capital BDC is subject to asset coverage requirements and other limitations on leverage and investments. The company’s public disclosures and rating reports reference regulatory asset coverage tests and a target gross leverage range, as well as covenants associated with its debt facilities and privately placed senior unsecured notes. The company has entered into a Master Note Purchase Agreement and subsequent supplements to issue senior unsecured notes with fixed interest rates and stated maturities, and has disclosed that it intends to use proceeds from certain note issuances to repay existing indebtedness and for general corporate purposes, including investing in portfolio companies in line with its investment objective.

In addition to bank credit facilities, Crescent Capital BDC has a mix of secured and unsecured debt. Rating agency analysis highlights a funding mix that includes bank lines and capital markets debt, as well as available liquidity in the form of undrawn capacity on credit facilities and cash and cash equivalents. The company’s SEC filings and earnings releases also reference its debt-to-equity ratio and asset coverage levels, which are important metrics for BDC investors monitoring leverage and regulatory compliance.

Portfolio characteristics and income generation

Crescent Capital BDC’s periodic earnings releases provide detail on its portfolio size, composition and performance. These disclosures show a portfolio invested in hundreds of portfolio companies with aggregate fair value in the billions of dollars, diversified across multiple sectors. The company reports a high percentage of its debt investments at floating rates, and provides a weighted average yield on income-producing securities at cost. Its investment income consists primarily of interest income on debt investments, including amortization of upfront fees and paid-in-kind interest, supplemented by dividend income and other fees.

The company’s results of operations, as presented in its financial statements, show net investment income after expenses such as interest and other debt financing costs, management fees, income-based incentive fees, professional fees, directors’ fees and other general and administrative expenses. Crescent Capital BDC’s Board of Directors has declared regular cash dividends per share and, at times, supplemental or special distributions, as disclosed in its press releases. These distributions reflect the company’s status as a RIC and its focus on returning a significant portion of its investment company taxable income to shareholders.

Risk considerations

Public commentary from rating agencies on Crescent Capital BDC notes both strengths and risks. Positive factors include its connection to the Crescent Capital Group platform, diversified portfolio of primarily secured loans, and access to multiple funding sources. At the same time, the company is exposed to risks common to BDCs and private credit strategies, including the illiquid nature of many portfolio investments, sensitivity to economic conditions that may affect portfolio company performance, and the potential for non-accruals. As a RIC, Crescent Capital BDC also faces constraints on retained earnings, which can influence its ability to build capital through earnings over time.

Exchange listings and industry classification

Crescent Capital BDC’s common stock is listed on Nasdaq under the ticker CCAP. The company’s 5.00% Notes due 2026 are listed on the New York Stock Exchange under the symbol FCRX, as disclosed in its SEC filings. In industry classification terms, the company is described as a business development company and is associated with the finance and insurance sector. Data sources also classify it within the broader category of securities and commodity exchanges, reflecting its role as a publicly traded investment company.

Use for investors and researchers

For investors, Crescent Capital BDC represents an exchange-traded vehicle that provides exposure to a portfolio of private credit investments in U.S. middle market companies. Its regular financial reporting, SEC filings, and rating agency coverage offer detailed information on portfolio composition, leverage, asset quality, and distribution policies. Researchers and analysts can follow CCAP’s disclosures to track trends in private credit markets, middle market lending, and the performance of BDCs that focus on below investment grade credit.

Stock Performance

$9.61
+2.73%
+0.26
Last updated: November 4, 2026 at 10:14
-34.5%
Performance 1 year
$353.9M

Crescent Capital BDC (CCAP) closed at $9.35 on November 3, 2026. Over the past 12 months, the price has lost 34.5%.

See what a $1,000 investment in CCAP would be worth today

Average down calculator for CCAP

CCAP Metrics & Rankings

Price returns through November 3, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Crescent Capital BDC has 10 recent news articles, with the latest published 5 days ago. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include conferences, earnings date, dividends, earnings. View all CCAP news →

Insider Radar

Net Sellers
90-Day Summary
4,500
Shares Bought
525,000
Shares Sold
14
Transactions
Most Recent Transaction
FIDELITY & GUARANTY LIFE INSURANCE CO (10% Owner) sold 139,054 shares @ $10.23 on September 9, 2026

Insider selling at Crescent Capital BDC over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.

Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

Crescent Capital BDC generated $167.3M in revenue in FY2025, operating income reached -$98.7M (-59.0% operating margin), and net income was $34.5M, reflecting a 20.6% net profit margin. Diluted earnings per share stood at $1.81. The company generated $74.7M in operating cash flow.

$167.3M
Revenue (FY2025)
$34.5M
Net Income (FY2025)
$74.7M
Operating Cash Flow

Upcoming Events

NOV
09
November 9, 2026 Earnings

Q3 2026 Results Release

Crescent Capital BDC will release Q3 2026 financial results after market close; covers quarter ended 2026-09-30.
NOV
10
November 10, 2026 Earnings

Q3 2026 Webcast Call

Conference call and webcast to discuss Q3 2026 results on Nov 10 at 12:00 p.m. ET; replay on the company IR website.

Crescent Capital BDC has 2 upcoming scheduled events. The next event, "Q3 2026 Results Release", is scheduled for November 9, 2026 (in 5 days). All of them are earnings releases or calls. Investors can track these dates to stay informed about potential catalysts that may affect the CCAP stock price.

Short Interest History

Last 12 Months

Short interest in Crescent Capital BDC (CCAP) currently stands at 808.0 thousand shares, down 3.9% from the previous reporting period, representing 2.4% of the float. Since November 2025, short interest has increased by 261.8%.

Days to Cover History

Last 12 Months

Days to cover for Crescent Capital BDC (CCAP) currently stands at 3.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 92.9%. Across the settlements charted above, it has ranged from 1.2 to 3.8 days.

CCAP Company Profile & Sector Positioning

Crescent Capital BDC (CCAP) operates in the Asset Management industry within the broader Financial Services sector and is listed on the NASDAQ.

Investors comparing CCAP often look at related companies in the same sector, including BlackRock TCP Capital Corp. (TCPC), CION Investment Corporation (CION), Palmer Square Capital BDC Inc. (PSBD), Eagle Point Credit Company (ECC), and Barings Corporate Investors (MCI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CCAP's relative position within its industry.

Frequently Asked Questions

The current stock price of Crescent Capital BDC (CCAP) is $9.61 as of November 4, 2026.

The market cap of Crescent Capital BDC (CCAP) is approximately $353.9M. Learn more about what market capitalization means .

The FY2025 revenue of Crescent Capital BDC (CCAP) is $167.3M, from its most recent completed fiscal year.

The FY2025 net income of Crescent Capital BDC (CCAP) is $34.5M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Crescent Capital BDC (CCAP) is $1.81 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Crescent Capital BDC (CCAP) is $74.7M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Crescent Capital BDC (CCAP) is 20.6% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Crescent Capital BDC (CCAP) is -59.0% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The operating income of Crescent Capital BDC (CCAP) is -$98.7M for FY2025, its most recent completed fiscal year. Learn about operating income.

Crescent Capital BDC, Inc. is a closed-end, externally managed business development company that seeks to maximize total return for its stockholders through current income and capital appreciation. It does this by providing capital solutions to middle market companies, primarily through debt and related equity investments, as described in its public disclosures.

According to its financial statements, Crescent Capital BDC generates investment income mainly from interest on its debt investments, including amortization of upfront fees and paid-in-kind interest. It also earns dividend income from certain investments and other income such as consent, waiver, amendment, agency, underwriting and arranger fees.

Company earnings releases show that Crescent Capital BDC’s portfolio includes senior secured first lien loans, unitranche first lien loans (including last-out tranches), senior secured second lien loans, unsecured debt, equity and other investments, and LLC/LP equity interests. The portfolio is diversified across many portfolio companies and sectors.

Crescent Capital BDC has elected to be regulated as a business development company under the Investment Company Act of 1940. It also elects to be treated as a regulated investment company for U.S. federal income tax purposes, which requires it to distribute at least 90% of its investment company taxable income to shareholders, as noted in rating and company disclosures.

Crescent Capital BDC is externally managed by Crescent Cap Advisors, LLC, a subsidiary of Crescent Capital Group LP. Company press releases state that Crescent BDC utilizes Crescent’s extensive experience, origination capabilities and disciplined investment process in sourcing and managing its investments.

According to its SEC filings, Crescent Capital BDC’s common stock trades on The Nasdaq Stock Market under the symbol CCAP. Its 5.00% Notes due 2026 are listed on the New York Stock Exchange under the symbol FCRX.

Crescent Capital BDC states that its investment objective is to maximize the total return of its stockholders in the form of current income and capital appreciation. It aims to achieve this by providing capital solutions to middle market companies with sound business fundamentals and strong growth prospects.

Public filings and rating reports indicate that Crescent Capital BDC finances its portfolio with a combination of bank credit facilities and senior unsecured notes issued under a Master Note Purchase Agreement and related supplements. The company is subject to regulatory asset coverage requirements and covenants that address leverage, minimum shareholders’ equity, and interest coverage.

Crescent Capital Group LP is the parent of Crescent Cap Advisors, LLC, CCAP’s external manager. Rating agency commentary notes that Crescent Capital BDC benefits from its ties to the Crescent platform, including co-investment capabilities and the broader firm’s experience in below investment grade credit across senior bank loans, high yield bonds, and private debt strategies.

Crescent Capital BDC’s Board of Directors declares regular cash dividends per share, and the company has also disclosed supplemental and special distributions in certain periods. These distributions reflect its status as a regulated investment company, which requires it to distribute a high percentage of its investment company taxable income to shareholders.